Laryngeal cancer medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(33 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Laryngeal cancer}}
{{Laryngeal cancer}}
{{CMG}}
{{CMG}} {{AE}}{{OK}}
==Overview==
==Overview==
The optimal therapy for laryngeal cancer depends on the stage at the time of diagnosis.
The [[medical]] therapy combined with [[radiation]] has largely replaced the [[Surgery|surgical]] cure for [[laryngeal cancer]]. However, the treatment truly depends on the stage at the time of [[diagnosis]]. Multiple factors should be taken into account when considering treatment such as [[laryngeal]] preservation, maintaining the [[airway]], s[[Swallowing|wallowing]] and s[[Speech|peech]]. Induction therapy includes three cycles of continuous infusion of [[cisplatin]] (100 mg/m2 on day 1) plus [[fluorouracil]] (1000 mg/m2/day) followed by definitive [[radiation therapy]] in the induction phase and concurrent consists of [[cisplatin]] (100 mg/m2 on days 1, 22, and 43) with [[radiation therapy]].


==Medical Therapy==
==Medical Therapy==
The optimal therapy for laryngeal cancer depends on the stage at the time of diagnosis.
The [[medical]] therapy combined with [[radiation]] has largely replaced the surgical cure for [[laryngeal cancer]]. However, the treatment truly depends on the stage at the time of [[diagnosis]].<ref name="pmid17453448">{{cite journal |vauthors=Tamura Y, Tanaka S, Asato R, Hirano S, Yamashita M, Tamaki H, Ito J |title=Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years |journal=Acta Otolaryngol Suppl |volume= |issue=557 |pages=62–5 |date=February 2007 |pmid=17453448 |doi=10.1080/00016480601067990 |url=}}</ref> Multiple factors should be taken into account when considering treatment: <ref name="pmid19306746">{{cite journal |vauthors=Lefebvre JL, Ang KK |title=Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary |journal=Int. J. Radiat. Oncol. Biol. Phys. |volume=73 |issue=5 |pages=1293–303 |date=April 2009 |pmid=19306746 |doi=10.1016/j.ijrobp.2008.10.047 |url=}}</ref><ref name="pmid19283793">{{cite journal |vauthors=Lefebvre JL, Ang KK |title=Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary |journal=Head Neck |volume=31 |issue=4 |pages=429–41 |date=April 2009 |pmid=19283793 |doi=10.1002/hed.21081 |url=}}</ref>
Treatment according to stages is as follows:<ref name=aaa>Treatment of laryngeal cancer according to stages. http://www.cancer.gov/types/head-and-neck/patient/laryngeal-treatment-pdq#section/_84</ref>
* [[Laryngeal]] preservation
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center
* Maintaining the [[airway]]
|valign=top|
* [[Swallowing]]
|+
* [[Speech]] 
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Stage}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Treatment}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center |
Stage 1
| style="padding: 5px 5px; background: #F5F5F5;" |
If cancer is in the supraglottis, treatment may include the following:


Radiation therapy.
=== Chemotherapy: ===
Supraglottic laryngectomy.
[[Chemotherapy]] consists of two phases:<ref name="pmid14645636">{{cite journal |vauthors=Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J |title=Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer |journal=N. Engl. J. Med. |volume=349 |issue=22 |pages=2091–8 |date=November 2003 |pmid=14645636 |doi=10.1056/NEJMoa031317 |url=}}</ref><ref name="pmid23182993">{{cite journal |vauthors=Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, Thorstad W, Wagner H, Ensley JF, Cooper JS |title=Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer |journal=J. Clin. Oncol. |volume=31 |issue=7 |pages=845–52 |date=March 2013 |pmid=23182993 |pmc=3577950 |doi=10.1200/JCO.2012.43.6097 |url=}}</ref>


If cancer is in the glottis, treatment may include the following:
'''Induction''': Three cycles of continuous infusion of [[cisplatin]] (100 mg/m2 on day 1) plus [[fluorouracil]] (1000 mg/m2/day )  followed by definitive [[radiation therapy]] in the induction phase


Radiation therapy.
'''Concurrent:''' [[Cisplatin]] (100 mg/m2 on days 1, 22, and 43) with [[radiation therapy]]
Cordectomy.
Partial laryngectomy, hemilaryngectomy, or total laryngectomy.
Laser surgery.


If cancer is in the subglottis, treatment may include the following:
=== '''Radiation therapy''' ===
 
[[Radiotherapy]] can be very helpful in preserving the [[larynx]] and [[voice]]. It has shown similar [[efficacy]] with concomitant [[cisplatin]] as the [[laryngectomy]]-free survival <ref name="pmid23007323">{{cite journal |vauthors=Smee RI, Williams JR, Broadley K, Bridger GP |title=Early glottic carcinoma treated by radiotherapy: defining a population for surgical salvage |journal=Laryngoscope |volume=123 |issue=1 |pages=171–6 |date=January 2013 |pmid=23007323 |doi=10.1002/lary.23663 |url=}}</ref><ref name="pmid8783399">{{cite journal |vauthors=Carl J, Andersen LJ, Pedersen M, Greisen O |title=Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx |journal=Radiother Oncol |volume=39 |issue=3 |pages=229–33 |date=June 1996 |pmid=8783399 |doi= |url=}}</ref><ref name="pmid20153124">{{cite journal |vauthors=Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM |title=T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy |journal=Int. J. Radiat. Oncol. Biol. Phys. |volume=78 |issue=2 |pages=461–6 |date=October 2010 |pmid=20153124 |doi=10.1016/j.ijrobp.2009.08.066 |url=}}</ref>
Radiation therapy with or without surgery.
Surgery alone.
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" align=center |
Stage 2
| style="padding: 5px 5px; background: #F5F5F5;" |
Treatment of stage II laryngeal cancer depends on where cancer is found in the larynx.
 
If cancer is in the supraglottis, treatment may include the following:
 
Radiation therapy.
Supraglottic laryngectomy or total laryngectomy with or without radiation therapy.
A clinical trial of radiation therapy.
A clinical trial of chemoprevention.
 
If cancer is in the glottis, treatment may include the following:
 
Radiation therapy.
Partial laryngectomy, hemilaryngectomy, or total laryngectomy.
Laser surgery.
A clinical trial of radiation therapy.
A clinical trial of chemoprevention.
 
If cancer is in the subglottis, treatment may include the following:
 
Radiation therapy with or without surgery.
Surgery alone.
A clinical trial of radiation therapy.
A clinical trial of chemoprevention.
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
Stage 3
| style="padding: 5px 5px; background: #F5F5F5;" |
Treatment of stage III laryngeal cancer depends on where cancer is found in the larynx.
 
If cancer is in the supraglottis or glottis, treatment may include the following:
 
Chemotherapy and radiation therapy given together.
Chemotherapy followed by chemotherapy and radiation therapy given together.Laryngectomy may be done if cancer remains.
Radiation therapy for patients who cannot be treated with chemotherapy and surgery. For tumors that do not respond to radiation, total laryngectomy may be done.
Surgery, which may be followed by radiation therapy.
A clinical trial of radiation therapy.
A clinical trial of chemotherapy, radiosensitizers, or radiation therapy.
A clinical trial of chemoprevention.
 
If cancer is in the subglottis, treatment may include the following:
 
Laryngectomy plus total thyroidectomy and removal of lymph nodes in the throat, usually followed by radiation therapy.
Radiation therapy with or without surgery.
A clinical trial of chemotherapy, radiosensitizers, or radiation therapy.
A clinical trial of chemoprevention.
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
Stage 4
| style="padding: 5px 5px; background: #F5F5F5;" |
Treatment of stage IV laryngeal cancer depends on where cancer is found in the larynx.
 
If cancer is in the supraglottis or glottis, treatment may include the following:
 
Chemotherapy and radiation therapy given together.
Chemotherapy followed by chemotherapy and radiation therapy given together.Laryngectomy may be done if cancer remains.
Radiation therapy for patients who cannot be treated with chemotherapy and surgery. For tumors that do not respond to radiation, total laryngectomy may be done.
Surgery followed by radiation therapy. Chemotherapy may be given with the radiation therapy.
A clinical trial of radiation therapy.
A clinical trial of chemotherapy, radiosensitizers, or radiation therapy.
A clinical trial of chemoprevention.
 
If cancer is in the subglottis, treatment may include the following:
 
Laryngectomy plus total thyroidectomy and removal of lymph nodes in the throat, usually with radiation therapy.
Radiation therapy.
A clinical trial of radiation therapy.
A clinical trial of chemotherapy, radiosensitizers, or radiation therapy.
A clinical trial of chemoprevention.
|-
|}
 
==Supportive Treatment==
Many patients also need swallowing rehabilitation after treatment to help them adjust to the changes in the structure of the throat.
 
===Radiation therapy===
There are two types of radiation therapy
* External radiation therapy
*Internal radiation therapy
*Radiation therapy may be helpful in patients who have stopped smoking before beginning treatment
*External radiation therapy to the thyroid or the pituitary gland may alter thyroid gland functioning
*Hyperfractionated radiation therapy and new types of radiation therapy are being studied in the treatment of laryngeal cancer
==References==
==References==
{{reflist|2}}
{{reflist|1}}


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
Line 125: Line 28:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Otolaryngology]]

Latest revision as of 00:44, 20 March 2019

Laryngeal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Laryngeal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Laryngeal cancer medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Laryngeal cancer medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Laryngeal cancer medical therapy

CDC on Laryngeal cancer medical therapy

Laryngeal cancer medical therapy in the news

Blogs on Laryngeal cancer medical therapy

Directions to Hospitals Treating Laryngeal cancer

Risk calculators and risk factors for Laryngeal cancer medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]

Overview

The medical therapy combined with radiation has largely replaced the surgical cure for laryngeal cancer. However, the treatment truly depends on the stage at the time of diagnosis. Multiple factors should be taken into account when considering treatment such as laryngeal preservation, maintaining the airway, swallowing and speech. Induction therapy includes three cycles of continuous infusion of cisplatin (100 mg/m2 on day 1) plus fluorouracil (1000 mg/m2/day) followed by definitive radiation therapy in the induction phase and concurrent consists of cisplatin (100 mg/m2 on days 1, 22, and 43) with radiation therapy.

Medical Therapy

The medical therapy combined with radiation has largely replaced the surgical cure for laryngeal cancer. However, the treatment truly depends on the stage at the time of diagnosis.[1] Multiple factors should be taken into account when considering treatment: [2][3]

Chemotherapy:

Chemotherapy consists of two phases:[4][5]

Induction: Three cycles of continuous infusion of cisplatin (100 mg/m2 on day 1) plus fluorouracil (1000 mg/m2/day ) followed by definitive radiation therapy in the induction phase

Concurrent: Cisplatin (100 mg/m2 on days 1, 22, and 43) with radiation therapy

Radiation therapy

Radiotherapy can be very helpful in preserving the larynx and voice. It has shown similar efficacy with concomitant cisplatin as the laryngectomy-free survival [6][7][8]

References

  1. Tamura Y, Tanaka S, Asato R, Hirano S, Yamashita M, Tamaki H, Ito J (February 2007). "Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years". Acta Otolaryngol Suppl (557): 62–5. doi:10.1080/00016480601067990. PMID 17453448.
  2. Lefebvre JL, Ang KK (April 2009). "Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary". Int. J. Radiat. Oncol. Biol. Phys. 73 (5): 1293–303. doi:10.1016/j.ijrobp.2008.10.047. PMID 19306746.
  3. Lefebvre JL, Ang KK (April 2009). "Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary". Head Neck. 31 (4): 429–41. doi:10.1002/hed.21081. PMID 19283793.
  4. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J (November 2003). "Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer". N. Engl. J. Med. 349 (22): 2091–8. doi:10.1056/NEJMoa031317. PMID 14645636.
  5. Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, Thorstad W, Wagner H, Ensley JF, Cooper JS (March 2013). "Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer". J. Clin. Oncol. 31 (7): 845–52. doi:10.1200/JCO.2012.43.6097. PMC 3577950. PMID 23182993.
  6. Smee RI, Williams JR, Broadley K, Bridger GP (January 2013). "Early glottic carcinoma treated by radiotherapy: defining a population for surgical salvage". Laryngoscope. 123 (1): 171–6. doi:10.1002/lary.23663. PMID 23007323.
  7. Carl J, Andersen LJ, Pedersen M, Greisen O (June 1996). "Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx". Radiother Oncol. 39 (3): 229–33. PMID 8783399.
  8. Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM (October 2010). "T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy". Int. J. Radiat. Oncol. Biol. Phys. 78 (2): 461–6. doi:10.1016/j.ijrobp.2009.08.066. PMID 20153124.


Template:WikiDoc Sources